
| 10.1161/CIRCULATIONAHA.116.025505
http://scihub22266oqcxt.onion/10.1161/CIRCULATIONAHA.116.025505
 C5401621!5401621
!28159799
free
free
free
Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28159799
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
|  
Circulation
2017 ; 135
(16
): 1494-1505
Nephropedia Template TP
gab.com Text
|
High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical
and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis)
#MMPMID28159799
Seliger SL
; Hong SN
; Christenson RH
; Kronmal R
; Daniels LB
; Lima JAC
; de Lemos JA
; Bertoni A
; deFilippi CR
Circulation
2017[Apr]; 135
(16
): 1494-1505
PMID28159799
show ga
BACKGROUND: Although small elevations of high-sensitive cardiac troponin T
(hs-cTnT) are associated with incident heart failure (HF) in the general
population, the underlying mechanisms are not well defined. Evaluating the
association of hs-cTnT with replacement fibrosis and progression of structural
heart disease before symptoms is fundamental to understanding the potential of
this biomarker in a HF prevention strategy. METHODS: We measured hs-cTnT at
baseline among 4986 participants in MESA (Multi-Ethnic Study of Atherosclerosis),
a cohort initially free of overt cardiovascular disease (CVD). Cardiac magnetic
resonance imaging was performed at baseline. Repeat cardiac magnetic resonance
was performed 10 years later among 2831 participants who remained free of interim
CVD events; of these, 1723 received gadolinium-enhanced cardiac magnetic
resonance for characterization of replacement fibrosis by late gadolinium
enhancement. Progression of subclinical CVD was defined by 10-year change in left
ventricular structure and function. Associations of hs-cTnT with incident HF,
CV-related mortality, and coronary heart disease were estimated using Cox
regression models. RESULTS: Late gadolinium enhancement for replacement fibrosis
was detectable in 6.3% participants without interim CVD events by follow-up
cardiac magnetic resonance. A graded association was observed between higher
baseline hs-cTnT categories and late gadolinium enhancement (?7.42 ng/L versus
12% (highest category versus | 
|